Keefe Bruyette cuts NB Bancorp stock price target on credit costs

Keefe Bruyette & Woods reduced its price target for NB Bancorp (NBBK) to $24 from $25, citing elevated credit costs from the Provident portfolio. The firm maintains a Market Perform rating, noting stable net interest margins and modest asset sensitivity. Shares trade at 9.2 times 2027 estimates, with InvestingPro suggesting undervaluation.

Original reporting
Published Oct 27, 2026, 2:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 2:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$NBBK
Bearish
high confidence
Mentioned
$NBBK
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NBBKBearishMed
01

Why it matters

Analyst price‑target reduction reflects concerns over credit costs and portfolio issues, which may trigger short‑term selling.

02

Market read

The downgrade adds fresh negative sentiment to NB Bancorp and could influence peers in the regional banking space.

03

What to watch

The impact of the Provident portfolio resolution timeline and any upcoming loan‑rate changes.

Relevance 6/10Novelty 5/10Timing: today

Background

NB Bancorp operates in a competitive New England market with a high proportion of variable‑rate loans.

Company-level read

Ticker impact

$NBBKBearishHigh confidence
Context

Keefe, Bruyette & Woods lowered its price target on NB Bancorp to $24 from $25, citing elevated credit costs and a work‑through of the Provident portfolio.

Expected impact

likely pressure as the market prices in higher credit costs and a lower valuation.

Evidence & confidence

The downgrade is a fresh analyst action with a concrete new target, which can prompt short‑term selling.

Market effects

May weigh on regional banks and lenders with similar credit‑cost exposure.

Potential modest pullback in New England banking stocks.

Limited to U.S. regional banking sector.

Counterpoint

If the credit‑cost concerns are overstated, the stock could rebound on its growth narrative.

Key entities

  • NB Bancorp Inc

    Regional bank targeted by the analyst note.

  • Keefe, Bruyette & Woods

    Equity research firm issuing the price‑target cut.

Related articles

$NBBKMedAI 8/10

NB Bancorp Q3FY26 Results: EPS $0.60 beats estimate, sales miss by 1%

NB Bancorp reported Q3FY26 adjusted operating EPS of $0.60, beating estimates by 1.69% but missing sales expectations by 1%. Revenue grew 47.98% year-over-year to $76.545 million. The company declared a $0.07 quarterly dividend. Net income rose to $23.1 million, with total assets increasing 3.2% to $7.68 billion. Non-performing loans rose 30.4% due to a commercial real estate loan.

$NBBKMed

NB Bancorp, Inc. (NBBK) Q3 Earnings Beat Estimates

NB Bancorp (NBBK) reported Q3 earnings of $0.60 per share, beating estimates by $0.01. Revenue was $76.55M, missing estimates by 0.85%. The company has surpassed EPS estimates three times in the last four quarters. Shares are up 11.7% YTD. Management's commentary on the earnings call may influence future stock performance.